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Background/aim: Psoriasis is an immune-mediated chronic inflammatory skin disease that is seen in 1%–3% of the population.
It is characterized by symmetrical papulosquamous lesions on the scalp, knees, elbows, sacral region, and extensor surfaces of the
extremities. Psoriasis affects both sexes equally. It is thought that reactive oxygen species have an important role in inflammatory skin
diseases, especially in psoriasis. There are few studies investigating serum oxidant-antioxidant levels in psoriasis. In this study, we aimed
to investigate serum oxidant and antioxidant levels in psoriasis and their effects on its pathogenesis.
Materials and methods: Included in this study were 50 patients with psoriasis who had not been treated with any systemic medication
and 45 healthy volunteers (control group). The total oxidant status (TOS), total antioxidant status (TAS), malondialdehyde (MDA), and
8-hydroxy 2’-deoxyguanosine (8H2D) were studied via venous blood sampling. The parameters were measured spectrophotometrically.
The study was approved by the Local Ethics Committee of the Atatürk University Faculty of Medicine.
Results: The mean ages of the patients and control group were 32.48 (±14.45) and 35.64 (±17.40) years, respectively. Of the patients, 23
were male and 27 were female. Of the healthy volunteers, 20 were male and 25 were female. The mean disease duration was 8.77 (±6.90)
years. The mean Psoriasis Area and Severity Index (PASI) score was 11.41 (±9.62). The mean TOS levels of the patient and control
groups were 63.12 (±33.23) and 4.50 (±9.74), respectively. This difference was statistically significant (P = 0.00). The mean TAS levels of
the patient and control groups were 3.15 (±0.70) and 3.16 (±0.44), respectively, without any statistically significant difference. The mean
MDA levels in the patient and control groups were 14.84 (±6.66) and 12.77 (±4.87), respectively, without any statistically significant
difference. The mean 8H2D levels of the patient and control groups were 16,781.2 (±5918.95) and 15,276.13 (±6084.95), respectively.
This difference was also not statistically significant. There was no correlation between PASI scores and the above-mentioned parameters.
Conclusion: In the present study, the TOS levels showed a significant statistical difference between the psoriasis and control groups.
This finding supports the effect of the oxidant system in the pathogenesis of psoriasis. This was the first study to investigate MDA,
TOS, TAS, and 8H2D levels together in patients with psoriasis. More studies are needed to clearly understand the relationship between
psoriasis and the oxidant-antioxidant system.
Key words: Psoriasis, total oxidant status, total antioxidant status, malondialdehyde, 8-hydroxy 2’-deoxyguanosine

1. Introduction
Psoriasis is a chronic inflammatory disease characterized
by erythematous scaly papules and plaques. A prevalence
of 1%–3% was found in different populations [1]. Lesions
are usually localized symmetrically on the scalp, sacral
region, and extensor surfaces of the extremities [2].
The disease affects both sexes equally. It may be seen
at any age. Psoriasis has been defined as a systemic
disease or a metabolic syndrome because of its relation
to some systemic comorbid diseases [3]. Nowadays,
it is thought that the oxidant and antioxidant systems

have a crucial role in the pathogenesis of the disease
[4]. When the literature was reviewed, there were few
studies investigating the oxidant and antioxidant systems
in relation to psoriasis, and the results of these studies
were controversial [5,6]. We aimed to understand the
pathogenesis of psoriasis better by investigating oxidant
and antioxidant parameters. To our knowledge, this was
the first study investigating malondialdehyde (MDA), total
oxidant status (TOS), total antioxidant status (TAS), and
8-hydroxy 2’-deoxyguanosine (8H2D) levels in patients
with psoriasis.
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2. Materials and methods
Included in this study were 50 patients and 45 age- and
sex-matched healthy volunteers. Patients receiving
systemic treatments and pregnant patients were excluded.
The age, sex, clinical history, dermatologic findings, and
Psoriasis Area and Severity Index (PASI) score were
recorded for each patient. Blood samples were left at 25 °C
for 30 min without adding any anticoagulant. Next, they
were centrifuged at 2000 rpm for 15 min at 4 °C. Serum
samples were frozen at –80 °C. The TOS, TAS, MDA, and
8H2D levels were studied for each patient and volunteer.
The parameters were measured spectrophotometrically, all
of which were statistically compared between the patients
and volunteers. The study was approved by the Local Ethics
Committee of the Atatürk University Faculty of Medicine.
2.1. Malondialdehyde
For the colorimetric standard of MDA, 8 standard samples
were prepared. First, 100 µL of sodium dodecyl sulfate was
added to 100 µL serum. The mixture was then added to the
bottom of Color Regain mixture and centrifuged at 1600
rpm. Next, 150 µL of each sample was taken and placed on
the plate for colorimetric measurement.
2.2. 8-Hydroxy 2’-deoxyguanosine
The samples were diluted 2 times. The EIA standard was
prepared. First, 100 µL of the standard sample was diluted
with 900 µL of ultrapure water. The solution concentration
was 30 ng/mL. A total of 8 tubes were prepared for the
standard. Then 900 µL of EIA buffer was added to tube 1,
and 500 µL of EIA buffer was added to tubes 2–8. Next, 100
µL of bulk was added to tube 1. Following that, 400 µL of
sample was transferred from tube 1 to tube 2 and a serial
dilution was performed for the other tubes. The samples
were covered with plastic film and incubated at 4 °C for 18
h. To each tube, 200 µL of Ellman reagent and 500 µL of
tracer were added. The samples were measured at 410 nm.
2.3. Total antioxidant status
For the preparation of the CAL standard, 30 µL sample
was used. For reagent 1, 500 µL of sample and 500 µL of
standard were mixed. For reagent 2, 75 µL of sample and
75 µL of standard were mixed. The samples were measured
spectrophotometrically at 660 nm and 37 °C.
2.4. Total oxidant status
For reagent 1, 500 µL of sample and 500 µL of standard
were mixed. For reagent 2, 25 µL of sample and 25 µL
of standard were mixed. The samples were measured
spectrophotometrically at 660 nm and 37 °C.
2.5. Statistical evaluation
The Student t-test and chi-square test were used to evaluate
differences between the groups. Correlation analyses were
performed via Pearson’s correlation test. P < 0.05 was
accepted as statistically significant.
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3. Results
The mean age was 32.48 (±14.45) and 35.64 (±17.40)
years for the patients and the control group, respectively.
Of the patients, 23 were male and 27 were female. In
the control group, 20 were male and 25 were female. No
significant relationship was found between the patients
and the control group in terms of age (P = 0.34) or sex
(P = 0.88). The mean disease duration was 8.77 (±6.90)
years. Of the patients, 13 had only psoriatic skin lesions
without itching, 35 had itchy psoriatic skin lesions, and 2
had itchy psoriatic skin lesions and arthralgia. There was
a history of arthritis in 5 patients. The mean PASI score
was 11.41 (±9.62). The PASI scores were classified as mild
(0–9 points) in 29 patients, moderate (10–19 points) in
10 patients, and severe (≥20 points) in 11 patients. Only
3 patients showed nail involvement. The demographic and
clinical parameters are provided in Table 1.
The mean TOS level was 63.12 (±33.23) for the patients
and 14.50 (±9.74) for the control group. The TOS levels
were significantly higher for patients when compared to
the control group (P < 0.00). The mean TAS level was 3.15
(±0.70) for the patients and 3.16 (±0.44) for the control
group. The TAS levels showed no significant difference
between the patients and the control group (P = 0.91).
The mean MDA level was 14.84 (±6.66) for the patients
and 12.77 (±4.87) for the control group. The MDA levels
also showed no significant difference between the patients
and the control group (P = 0.11). The mean 8H2D level
was 16,781.2 (±5918.95) for the patients and 15,276.13
(±6084.95) for the control group. There was no significant
difference between the patients and the control group for
8H2D values (P = 0.26). There was also no correlation
between the PASI scores and TAS (P = 0.85), MDA (P =
0.18), 8H2D (P = 0.96), or TOS (P = 0.67) levels. The mean
levels of MDA, TOS, TAS, and 8H2D in the patients and
the control group are given in Table 2.
4. Discussion
When the literature was reviewed, there were some studies
suggesting that oxidative stress plays an important role
in the pathogenesis of multifactorial skin diseases like
psoriasis, atopic dermatitis, and vitiligo. These diseases
showed increased levels of oxidant molecules and
decreased levels of antioxidant molecules as a result of lipid
peroxidation [7]. It has been considered that an increased
number of neutrophils causes increased levels of reactive
oxygen species and releases proteolytic enzymes that
destroy the surrounding tissue. Increased levels of reactive
oxygen species cause increased levels of phospholipase
A2 and lipid peroxidation. As a result, cyclic adenosine
monophosphate (cAMP) is deactivated but cyclic guanosine
monophosphate (cGMP) is activated. Decreasing the
cAMP/cGMP ratio causes epidermal hyperproliferation
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Table 1. Demographic and clinical parameters in patients and control group.
Patients

Control group

Mean age

32.48 years

35.64 years

Sex

Male: 23, female: 27

Male: 20, female: 25

Mean disease duration

8.77 years

-

Patients with only skin lesions

13

-

Patients with skin lesions and itching

35

-

Patients with skin lesions, itching, and arthralgia

2

-

PASI score

Mild (0–9 points): 29 patients
Moderate (10–19 points): 10 patients
Severe (≥20 points): 11 patients

-

Table 2. Mean MDA, TOS, TAS, and 8H2D levels in patients and
control group.
Patients

Control group

P-value

Mean MDA

14.84

12.77

P = 0.11

Mean TOS

63.12

14.50

P < 0.00*

Mean TAS

3.15

3.16

P = 0.91

Mean 8H2D

16,781.2

15,276.13

P = 0.26

*Statistically significant.

in psoriasis [8]. As a natural response, the antioxidant
system is activated when the oxidant system is activated.
However, this response is insufficient in psoriasis [9] and
reactive oxygen species seem to be related to the activation
of psoriatic lesions. It has been shown that reactive oxygen
species have chemotactic effects on neutrophils [10]. There
have been some studies investigating the oxidant and
antioxidant systems in psoriasis with controversial results.
Kural et al. found that the MDA and lipid peroxide levels
were increased but the catalase, superoxide dismutase
(SOD), glutathione peroxidase, and TAS levels were
decreased in patients when compared to the control group
[6]. Kökçam et al. and Wozniak et al. also found that MDA
levels were increased in patients with psoriasis [11,12]. In
the present study, no significant difference was observed
in MDA levels between the patients and the control group.
Baz et al. found that MDA and SOD levels were increased
and the antioxidant potential was decreased in patients
with psoriasis [4]. In this study, there was no correlation
between PASI scores and MDA, SOD, or antioxidant
potential. Emre et al. found that TAS levels were decreased
and TOS levels were increased in psoriasis and there was
no relation between PASI scores and TAS or TOS [13]. The

present study also found that TOS levels were increased
but TAS levels were not decreased in the patient group and
there was no correlation between PASI scores and oxidantantioxidant parameters. Kadam et al. [14] and Gabr et al.
[15] found that MDA levels were increased and TAS levels
were decreased in patients with psoriasis. Kaur et al. found
that TAS levels were decreased in their patients [16]. In
our study, there was no significant difference in TAS and
MDA levels between the two groups.
As mentioned above, there have been some studies
investigating MDA levels in psoriasis and these studies
showed controversial results. Yıldırım et al. studied MDA
levels in both blood and tissue samples and found no
statistically significant increase in MDA levels in the blood
samples. However, they showed that there was a significant
increase in the tissue samples [7]. In a study by Severin et
al., there was no significant difference in TAS levels [5].
Usta et al. detected no significant changes in TOS and TAS
levels for patients with psoriasis [17]. In the present study,
increased TOS levels were detected in the patient group.
However, no significant difference was observed in TAS
levels between the two groups. With regards to 8H2D, there
have been a few studies investigating urine levels of 8H2D,
but to the best of our knowledge, there have not been
any studies investigating 8H2D levels in blood samples.
Hence, this was the first study investigating blood levels of
8H2D in psoriasis. In our study, there was no significant
difference in 8H2D levels between the groups. Similarly,
Toker et al. also found that the lipid, MDA, and TAS levels
were not significantly different in psoriasis cases when
compared to a control group; however, the paraoxonase
and arylesterase levels were significantly higher [18].
Houshang et al. found that MDA levels were increased
and paraoxonase levels were decreased in patients with
psoriasis [19]. The clinical type of the disease, demographic
features, treatments, and distribution of the lesions could
explain these controversial results. Different test methods
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may also cause different results. Oxidant and antioxidant
molecules can only pass in a certain amount from tissue to
serum. Therefore, the serum levels of the parameters may
not fully reflect the tissue levels. The use of tissue biopsy
materials may provide results that are more accurate.
It is thought that the balance of the oxidant and
antioxidant systems is disturbed in psoriasis. Studies
investigating oxidant and antioxidant levels in psoriasis
have shown controversial results. In the present study,
there was no significant difference in TAS, MDA, and
8H2D levels between the patients and the control group;

however, TOS levels were significantly higher in the patient
group. Therefore, we suggest that it is better to choose TOS
in order to determine oxidative stress in patients with
psoriasis. An important feature of the present research is
that this was the first study investigating blood levels of
8H2D in psoriasis. The most important limitation of our
study was the limited number of patients and controls.
Therefore, it is obvious that further studies with a larger
sample size are needed to clearly reveal the role of the
oxidant-antioxidant system in psoriasis.
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